Here are nine cancer studies and research you might have missed:
- A breast cancer vaccine has shown promise in a phase 1 trial spearheaded by researchers at Seattle-based University of Washington's Cancer Vaccine Institute and is preparing to move to phase 2.
- A World Health Organization analysis classified non-sugar sweetener aspartame as possibly carcinogenic to humans, but the FDA disagrees with the assessment.
- Researchers at Boston-based Mass General Cancer Center found a treatment that reduced a rare type of brain tumor by an average of 91 percent in a clinical trial.
- Preoperative magnetic resonance imaging does not "significantly reduce positive margins" following breast-conserving surgery.
- Scientists used CRISPR to cut extra chromosomes from cancer, showing that cancer cells cannot proliferate without them.
- Automated liquid biopsy tests developed by researchers at the Washington, D.C.-based Johns Hopkins Kimmel Cancer Center can predict early disease progression and potential survival among patients with metastatic breast cancer in as little as one month.
- Texas Health Harris Methodist Hospital Fort Worth found combining diagnosis and early lung cancer treatment into the same procedure, while the patient is under a single anesthesia, reduces time between detection, treatment, length of hospital stay and lowers rate of complications. to both diagnose and treat early lung cancer was recently published in a peer-reviewed journal.
- Washington, D.C.-based Johns Hopkins Kimmel Cancer Center researchers found Hispanic and Black female survivors of breast cancer experience higher death rates after being diagnosed with a second primary cancer.
- Investigators from Boston-based Mass General Brigham found a link between certain types of gut bacteria to the development of precancerous colon polyps.